Serina Therapeutics CEO presents on SER-252 Parkinson’s program in Tribe Public webinar Q&A
SERA•Webinar presentation scheduled for Sept. 24
Serina Therapeutics’ CEO Steven Ledger will present at a Tribe Public webinar on Sept. 24, 2026.
The session starts at 8:30 a.m. PST, 11:30 a.m. ET, and will focus on SER-252 clinical progress in advanced Parkinson’s disease.
The event will include a live Q&A segment.
